Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Marina I. Sekacheva"'
Autor:
Varvara D. Sanikovich, Marina I. Sekacheva, Ekaterina V. Orlova, Gaiane A. Gabrielian, Alexander M. Boroda, Juliya S. Agakina, Igor V. Reshetov
Publikováno v:
Consilium Medicum, Vol 26, Iss 6, Pp 386-395 (2024)
Squamous cell carcinoma of the head and neck is the sixth most common cancer worldwide. However, malignant tumors of the middle ear are extremely rare. Squamous cell carcinoma is the most common histologic type of tumor in this area, accounting for m
Externí odkaz:
https://doaj.org/article/011749596163470c917d0f54da4353d1
Publikováno v:
Современная онкология, Vol 25, Iss 4, Pp 490-497 (2023)
Aim. Evaluation of comorbid pathology in SARS-CoV-2 infected in cancer practice as a predictor of severe outcomes. Testing the COVID-19 risk assessment tool in oncology (CORONET), to predict the likely severity of COVID-19 course in cancer patients o
Externí odkaz:
https://doaj.org/article/2381d9c36fd1473798c5ffa5d8c810da
Autor:
Janneta R. Tcherkassova, Anna I. Prostyakova, Sergei A. Tsurkan, Nikolai V. Suganov, Alexander M. Boroda, Angelina V. Zhilenkova, Juliya N. Pirogova, Zaiana D. Sangadzhieva, Aleksandr S. Rusanov, Aleksandr A. Rozhkov, Anastasia S. Fatyanova, Natalia M. Nikitina, Nikolay N. Bagmet, Marina I. Sekacheva
Publikováno v:
Современная онкология, Vol 25, Iss 1, Pp 82-90 (2023)
Background. The combination of several diagnostic methods is used to predict treatment outcomes, assess overall survival, and increase the positive predictive value of detecting malignant lung and bronchial tumors. Aim. To evaluate the diagnostic
Externí odkaz:
https://doaj.org/article/7b46723762974c9faabcb267387cb894
Autor:
Maksim Sorokin, Anton A. Buzdin, Anastasia Guryanova, Victor Efimov, Maria V. Suntsova, Marianna A. Zolotovskaia, Elena V. Koroleva, Marina I. Sekacheva, Victor S. Tkachev, Andrew Garazha, Kristina Kremenchutckaya, Aleksey Drobyshev, Aleksander Seryakov, Alexander Gudkov, Irina V. Alekseenko, Olga Rakitina, Maria B. Kostina, Uliana Vladimirova, Aleksey Moisseev, Dmitry Bulgin, Elena Radomskaya, Viktor Shestakov, Vladimir P. Baklaushev, Vladimir Prassolov, Petr V. Shegay, Xinmin Li, Elena V. Poddubskaya, Nurshat Gaifullin
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 21, Iss , Pp 3964-3986 (2023)
Normal tissues are essential for studying disease-specific differential gene expression. However, healthy human controls are typically available only in postmortal/autopsy settings. In cancer research, fragments of pathologically normal tissue adjace
Externí odkaz:
https://doaj.org/article/bf4fa9cc991740c98706b792903a2914
Autor:
Marianna A. Zolotovskaia, Victor S. Tkachev, Anastasia A. Guryanova, Alexander M. Simonov, Mikhail M. Raevskiy, Victor V. Efimov, Ye Wang, Marina I. Sekacheva, Andrew V. Garazha, Nicolas M. Borisov, Denis V. Kuzmin, Maxim I. Sorokin, Anton A. Buzdin
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 2280-2291 (2022)
OncoboxPD (Oncobox pathway databank) available at https://open.oncobox.com is the collection of 51 672 uniformly processed human molecular pathways. Superposition of all pathways formed interactome graph of protein–protein interactions and metaboli
Externí odkaz:
https://doaj.org/article/b245b73cfa724537ad4253da67e83fa8
Autor:
Marina I. Sekacheva, Anastasia S. Fatyanova, Daur A. Meretukov, Angelina V Zhilenkova, Aleksandr S. Rusanov, Aleksandr A. Rozhkov, Anastasiia A. Guryanova, Nikolay N. Bagmet
Publikováno v:
Современная онкология, Vol 23, Iss 2, Pp 256-259 (2021)
Colorectal cancer (CRC) is one of the leading cancers in terms of prevalence and mortality. Almost 1/4 of patients with CRC have metastases at the initial presentation. The survival rate of this group of patients remains low. With the onset of the CO
Externí odkaz:
https://doaj.org/article/74b49f25f4074c698a61ce570af6f103
Publikováno v:
Терапевтический архив, Vol 93, Iss 6, Pp 649-660 (2021)
Immune checkpoint inhibitors (ICIs), including cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) and programmed death protein 1 (PD-1) or its ligand (PD-L1), are a new generation of immuno-oncological drugs that to date have demonstrated efficacy
Externí odkaz:
https://doaj.org/article/1d32c2e173f64b9aa68f053e583c8a20
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/e90574889e5149239918496a23a516a4
Autor:
Julian M. Rozenberg, Gleb I. Filkov, Alexander V. Trofimenko, Evgeny A. Karpulevich, Vladimir D. Parshin, Valery V. Royuk, Marina I. Sekacheva, Mikhail O. Durymanov
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung cancer (NSCLC), which is characterized by extremely high clonal and morphologica
Externí odkaz:
https://doaj.org/article/6febf9a3857d410ab3114c656c336ea8
Autor:
Elena V. Poddubskaya, Madina P. Baranova, Daria O. Allina, Philipp Y. Smirnov, Eugene A. Albert, Alexey P. Kirilchev, Alexey A. Aleshin, Marina I. Sekacheva, Maria V. Suntsova
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-7 (2018)
Abstract Background Cholangiocarcinoma is an aggressive tumor with poor prognosis. Most of the cases are not available for surgery at the stage of the diagnosis and the best clinical practice chemotherapy results in about 12-month median survival. Se
Externí odkaz:
https://doaj.org/article/5aff8e9e6a9a4c83a30cf2a8f905f4da